{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:56:49Z","timestamp":1790657809476,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Updates Surg"],"DOI":"10.1007\/s13304-026-02861-x","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:04:00Z","timestamp":1790611440000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A retrospective multicenter study: postoperative prognostic value of the lymphocyte-C-reactive protein ratio combined with the Ki-67 index in gallbladder cancer"],"prefix":"10.1007","author":[{"given":"Haijian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"2861_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/978-3-319-34244-3_6","volume":"168","author":"AE Ertel","year":"2016","unstructured":"Ertel AE, Bentrem D, Abbott DE (2016) Gall Bladder Cancer. Cancer Treat Res 168:101\u2013120. https:\/\/doi.org\/10.1007\/978-3-319-34244-3_6","journal-title":"Cancer Treat Res"},{"key":"2861_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12071630","author":"G Cassese","year":"2022","unstructured":"Cassese G, Han HS, Yoon YS et al (2022) Preoperative assessment and perioperative management of resectable gallbladder cancer in the era of precision medicine and novel technologies: state of the art and future perspectives. Diagnostics (Basel). https:\/\/doi.org\/10.3390\/diagnostics12071630","journal-title":"Diagnostics (Basel)"},{"issue":"7","key":"2861_CR3","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.trecan.2020.03.003","volume":"6","author":"PK Tiwari","year":"2020","unstructured":"Tiwari PK (2020) Epigenetic biomarkers in gallbladder cancer. Trends Cancer 6(7):540\u2013543. https:\/\/doi.org\/10.1016\/j.trecan.2020.03.003","journal-title":"Trends Cancer"},{"issue":"6","key":"2861_CR4","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ejso.2013.02.010","volume":"39","author":"M D\u2019Hondt","year":"2013","unstructured":"D\u2019Hondt M, Lapointe R, Benamira Z et al (2013) Carcinoma of the gallbladder: patterns of presentation, prognostic factors and survival rate. An 11-year single centre experience. Eur J Surg Oncol 39(6):548\u2013553. https:\/\/doi.org\/10.1016\/j.ejso.2013.02.010","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"2861_CR5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s12029-020-00397-w","volume":"52","author":"N Akhtar-Danesh","year":"2021","unstructured":"Akhtar-Danesh N, Akhtar-Danseh GG, Seow H et al (2021) Treatment modality and trends in survival for gallbladder cancer: a population-based study. J Gastrointest Cancer 52(1):256\u2013262. https:\/\/doi.org\/10.1007\/s12029-020-00397-w","journal-title":"J Gastrointest Cancer"},{"issue":"10","key":"2861_CR6","doi-asserted-by":"publisher","first-page":"106959","DOI":"10.1016\/j.ejso.2023.06.011","volume":"49","author":"Q Li","year":"2023","unstructured":"Li Q, Li N, Gao Q et al (2023) The clinical impact of early recurrence and its recurrence patterns in patients with gallbladder carcinoma after radical resection. Eur J Surg Oncol 49(10):106959. https:\/\/doi.org\/10.1016\/j.ejso.2023.06.011","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"2861_CR7","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/jhbp.1342","volume":"30","author":"T Minagawa","year":"2023","unstructured":"Minagawa T, Itano O, Hasegawa S et al (2023) Short- and long-term outcomes of laparoscopic radical gallbladder resection for gallbladder carcinoma: a multi-institutional retrospective study in Japan. J Hepatobiliary Pancreat Sci 30(8):1046\u20131054. https:\/\/doi.org\/10.1002\/jhbp.1342","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"2861_CR8","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jss.2018.04.067","volume":"230","author":"AJ Lee","year":"2018","unstructured":"Lee AJ, Chiang YJ, Lee JE et al (2018) Validation of American Joint Committee on Cancer eighth staging system for gallbladder cancer and its lymphadenectomy guidelines. J Surg Res 230:148\u2013154. https:\/\/doi.org\/10.1016\/j.jss.2018.04.067","journal-title":"J Surg Res"},{"issue":"3","key":"2861_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/aam.aam_56_18","volume":"18","author":"N Singh","year":"2019","unstructured":"Singh N, Baby D, Rajguru JP et al (2019) Inflammation and cancer. Ann Afr Med 18(3):121\u2013126. https:\/\/doi.org\/10.4103\/aam.aam_56_18","journal-title":"Ann Afr Med"},{"key":"2861_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/bs.apcsb.2019.09.004","volume":"119","author":"R Khandia","year":"2020","unstructured":"Khandia R, Munjal A (2020) Interplay between inflammation and cancer. Adv Protein Chem Struct Biol 119:199\u2013245. https:\/\/doi.org\/10.1016\/bs.apcsb.2019.09.004","journal-title":"Adv Protein Chem Struct Biol"},{"issue":"1","key":"2861_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12199-018-0740-1","volume":"23","author":"M Murata","year":"2018","unstructured":"Murata M (2018) Inflammation and cancer. Environ Health Prev Med 23(1):50. https:\/\/doi.org\/10.1186\/s12199-018-0740-1","journal-title":"Environ Health Prev Med"},{"issue":"3","key":"2861_CR12","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA (2023) The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41(3):374\u2013403. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.016","journal-title":"Cancer Cell"},{"issue":"12","key":"2861_CR13","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.26355\/eurrev_201806_15270","volume":"22","author":"JJ Wang","year":"2018","unstructured":"Wang JJ, Lei KF, Han F (2018) Tumor microenvironment: recent advances in various cancer treatments. Eur Rev Med Pharmacol Sci 22(12):3855\u20133864. https:\/\/doi.org\/10.26355\/eurrev_201806_15270","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"10","key":"2861_CR14","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1007\/s10147-021-01985-x","volume":"26","author":"N Iseda","year":"2021","unstructured":"Iseda N, Itoh S, Yoshizumi T et al (2021) Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma. Int J Clin Oncol 26(10):1890\u20131900. https:\/\/doi.org\/10.1007\/s10147-021-01985-x","journal-title":"Int J Clin Oncol"},{"key":"2861_CR15","doi-asserted-by":"publisher","first-page":"1131496","DOI":"10.3389\/fimmu.2023.1131496","volume":"14","author":"M Yang","year":"2023","unstructured":"Yang M, Lin SQ, Liu XY et al (2023) Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: from the investigation on nutrition status and clinical outcome of common cancers study. Front Immunol 14:1131496. https:\/\/doi.org\/10.3389\/fimmu.2023.1131496","journal-title":"Front Immunol"},{"issue":"3","key":"2861_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.hbpd.2021.08.006","volume":"21","author":"WY Yao","year":"2022","unstructured":"Yao WY, Wu XS, Liu SL et al (2022) Preoperative lymphocyte to C-reactive protein ratio as a new prognostic indicator in patients with resectable gallbladder cancer. Hepatobiliary Pancreat Dis Int 21(3):267\u2013272. https:\/\/doi.org\/10.1016\/j.hbpd.2021.08.006","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"3","key":"2861_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/modpathol.2016.203","volume":"30","author":"S Kitson","year":"2017","unstructured":"Kitson S, Sivalingam VN, Bolton J et al (2017) Ki-67 in endometrial cancer: scoring optimization and prognostic relevance for window studies. Mod Pathol 30(3):459\u2013468. https:\/\/doi.org\/10.1038\/modpathol.2016.203","journal-title":"Mod Pathol"},{"issue":"10","key":"2861_CR18","doi-asserted-by":"publisher","first-page":"e1196","DOI":"10.1016\/j.crad.2024.05.014","volume":"79","author":"M Zhang","year":"2024","unstructured":"Zhang M, Jing M, Li R et al (2024) Construction and validation of a prediction model for preoperative prediction of Ki-67 expression in endometrial cancer patients by apparent diffusion coefficient. Clin Radiol 79(10):e1196\u2013e1204. https:\/\/doi.org\/10.1016\/j.crad.2024.05.014","journal-title":"Clin Radiol"},{"issue":"3","key":"2861_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000345321","volume":"84","author":"M Ishihara","year":"2013","unstructured":"Ishihara M, Mukai H, Nagai S et al (2013) Retrospective analysis of risk factors for central nervous system metastases in operable breast cancer: effects of biologic subtype and Ki67 overexpression on survival. Oncology (Williston Park) 84(3):135\u2013140. https:\/\/doi.org\/10.1159\/000345321","journal-title":"Oncology (Williston Park)"},{"issue":"12","key":"2861_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1472-6890-12-7","volume":"3","author":"SW Sorbye","year":"2012","unstructured":"Sorbye SW, Kilvaer TK, Valkov A et al (2012) Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas. BMC Clin Pathol 3(12):7. https:\/\/doi.org\/10.1186\/1472-6890-12-7","journal-title":"BMC Clin Pathol"},{"issue":"11","key":"2861_CR21","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.14670\/HH-18-124","volume":"34","author":"WY Zhu","year":"2019","unstructured":"Zhu WY, Hu XF, Fang KX et al (2019) Prognostic value of mutant p53, Ki-67, and TTF-1 and their correlation with EGFR mutation in patients with non-small cell lung cancer. Histol Histopathol 34(11):1269\u20131278. https:\/\/doi.org\/10.14670\/HH-18-124","journal-title":"Histol Histopathol"},{"issue":"4","key":"2861_CR22","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1007\/s12029-018-0162-8","volume":"50","author":"S Halder","year":"2019","unstructured":"Halder S, Kundu S, Chakraborty J et al (2019) Significance of HER2 and Ki-67 in preneoplastic lesions and carcinoma of gallbladder. J Gastrointest Cancer 50(4):848\u2013854. https:\/\/doi.org\/10.1007\/s12029-018-0162-8","journal-title":"J Gastrointest Cancer"},{"issue":"2","key":"2861_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/s0304-3835(01)00749-2","volume":"176","author":"AM Hui","year":"2002","unstructured":"Hui AM, Shi YZ, Li X et al (2002) Proliferative marker Ki-67 in gallbladder carcinomas: high expression level predicts early recurrence after surgical resection. Cancer Lett 176(2):191\u2013198. https:\/\/doi.org\/10.1016\/s0304-3835(01)00749-2","journal-title":"Cancer Lett"},{"key":"2861_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4103\/1477-3163.139450","volume":"13","author":"DC Doval","year":"2014","unstructured":"Doval DC, Azam S, Sinha R et al (2014) Expression of epidermal growth factor receptor, p53, Bcl2, vascular endothelial growth factor, cyclooxygenase-2, cyclin D1, human epidermal receptor-2 and Ki-67: association with clinicopathological profiles and outcomes in gallbladder carcinoma. J Carcinog 13:10. https:\/\/doi.org\/10.4103\/1477-3163.139450","journal-title":"J Carcinog"},{"key":"2861_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3352\/jeehp.2021.18.17","volume":"18","author":"H Kang","year":"2021","unstructured":"Kang H (2021) Sample size determination and power analysis using the G*Power software. J Educ Eval Health Prof 18:17. https:\/\/doi.org\/10.3352\/jeehp.2021.18.17","journal-title":"J Educ Eval Health Prof"},{"key":"2861_CR26","doi-asserted-by":"publisher","first-page":"957407","DOI":"10.3389\/fimmu.2022.957407","volume":"13","author":"JN Zhang","year":"2022","unstructured":"Zhang JN, Gao Y, Wang XT et al (2022) Lymphocyte-C-reactive protein ratio can differentiate disease severity of COVID-19 patients and serve as an assistant screening tool for hospital and ICU admission. Front Immunol 13:957407. https:\/\/doi.org\/10.3389\/fimmu.2022.957407","journal-title":"Front Immunol"},{"issue":"1","key":"2861_CR27","doi-asserted-by":"publisher","first-page":"7217","DOI":"10.1038\/s41598-023-34096-w","volume":"13","author":"XY Liu","year":"2023","unstructured":"Liu XY, Zhang X, Zhang Q et al (2023) Lymphocyte-C-reactive protein ratio with calf circumference could better predict survival of patients with non-metastatic cancer. Sci Rep 13(1):7217. https:\/\/doi.org\/10.1038\/s41598-023-34096-w","journal-title":"Sci Rep"},{"issue":"1","key":"2861_CR28","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1186\/s12885-021-08693-9","volume":"21","author":"T Powles","year":"2021","unstructured":"Powles T, Choueiri TK, Motzer RJ et al (2021) Correction to: outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma. BMC Cancer 21(1):1023. https:\/\/doi.org\/10.1186\/s12885-021-08693-9","journal-title":"BMC Cancer"},{"issue":"8","key":"2861_CR29","doi-asserted-by":"publisher","first-page":"e66205","DOI":"10.7759\/cureus.66205","volume":"16","author":"A Kumari","year":"2024","unstructured":"Kumari A, Mishra G, Parihar P et al (2024) Role of magnetic resonance spectroscopy in evaluating choline levels in gallbladder carcinoma: a comprehensive review. Cureus 16(8):e66205. https:\/\/doi.org\/10.7759\/cureus.66205","journal-title":"Cureus"},{"issue":"10","key":"2861_CR30","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nrclinonc.2015.105","volume":"12","author":"SM Crusz","year":"2015","unstructured":"Crusz SM, Balkwill FR (2015) Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol 12(10):584\u2013596. https:\/\/doi.org\/10.1038\/nrclinonc.2015.105","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"2861_CR31","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","volume":"15","author":"CI Diakos","year":"2014","unstructured":"Diakos CI, Charles KA, McMillan DC et al (2014) Cancer-related inflammation and treatment effectiveness. Lancet Oncol 15(11):e493-503. https:\/\/doi.org\/10.1016\/S1470-2045(14)70263-3","journal-title":"Lancet Oncol"},{"key":"2861_CR32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1475-2891-9-69","volume":"9","author":"D Gupta","year":"2010","unstructured":"Gupta D, Lis CG (2010) Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J 9:69. https:\/\/doi.org\/10.1186\/1475-2891-9-69","journal-title":"Nutr J"},{"issue":"12","key":"2861_CR33","doi-asserted-by":"publisher","first-page":"e0143080","DOI":"10.1371\/journal.pone.0143080","volume":"10","author":"S Shrotriya","year":"2015","unstructured":"Shrotriya S, Walsh D, Bennani-Baiti N et al (2015) C-reactive protein is an important biomarker for prognosis tumor recurrence and treatment response in adult solid tumors: a systematic review. PLoS ONE 10(12):e0143080. https:\/\/doi.org\/10.1371\/journal.pone.0143080","journal-title":"PLoS ONE"},{"issue":"2","key":"2861_CR34","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/SLA.0000000000003239","volume":"272","author":"Y Okugawa","year":"2020","unstructured":"Okugawa Y, Toiyama Y, Yamamoto A et al (2020) Lymphocyte-C-reactive protein ratio as promising new marker for predicting surgical and oncological outcomes in colorectal cancer. Ann Surg 272(2):342\u2013351. https:\/\/doi.org\/10.1097\/SLA.0000000000003239","journal-title":"Ann Surg"},{"issue":"10","key":"2861_CR35","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2217\/bmm-2023-0270","volume":"17","author":"YJ Shao","year":"2023","unstructured":"Shao YJ, Yu GD, Zhang X et al (2023) Prognostic value of lymphocyte-C-reactive protein ratio in patients with liver cancer: a meta-analysis. Biomark Med 17(10):497\u2013507. https:\/\/doi.org\/10.2217\/bmm-2023-0270","journal-title":"Biomark Med"},{"issue":"11","key":"2861_CR36","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.hpb.2017.06.011","volume":"19","author":"Z Wen","year":"2017","unstructured":"Wen Z, Si A, Yang J et al (2017) Elevation of CA19-9 and CEA is associated with a poor prognosis in patients with resectable gallbladder carcinoma. HPB (Oxford) 19(11):951\u2013956. https:\/\/doi.org\/10.1016\/j.hpb.2017.06.011","journal-title":"HPB (Oxford)"},{"issue":"6","key":"2861_CR37","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/ans.14300","volume":"88","author":"R Saqib","year":"2018","unstructured":"Saqib R, Pathak S, Smart N et al (2018) Prognostic significance of pre-operative inflammatory markers in resected gallbladder cancer: a systematic review. ANZ J Surg 88(6):554\u2013559. https:\/\/doi.org\/10.1111\/ans.14300","journal-title":"ANZ J Surg"},{"issue":"7","key":"2861_CR38","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.4103\/jcrt.jcrt_2469_24","volume":"21","author":"S Gaba","year":"2025","unstructured":"Gaba S, Tewari M, Ansari MA (2025) Raised blood markers of chronic inflammation confer poor prognosis in gallbladder cancer. J Cancer Res Ther 21(7):1367\u20131374. https:\/\/doi.org\/10.4103\/jcrt.jcrt_2469_24","journal-title":"J Cancer Res Ther"},{"issue":"3","key":"2861_CR39","doi-asserted-by":"publisher","first-page":"e71646","DOI":"10.1002\/cam4.71646","volume":"15","author":"M Wang","year":"2026","unstructured":"Wang M, Chen Z et al (2026) Machine learning-driven prognostic model integrating lymphocyte-to-C-reactive protein ratio and TNM staging in gallbladder cancer. Cancer Med. 15(3):e71646. https:\/\/doi.org\/10.1002\/cam4.71646","journal-title":"Cancer Med."},{"issue":"4","key":"2861_CR40","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s13304-024-01774-x","volume":"76","author":"F Liu","year":"2024","unstructured":"Liu F, Wang JK, Ma WJ et al (2024) The prognostic value of combined preoperative PLR and CA19-9 in patients with resectable gallbladder cancer. Updates Surg 76(4):1235\u20131245. https:\/\/doi.org\/10.1007\/s13304-024-01774-x","journal-title":"Updates Surg"},{"issue":"10","key":"2861_CR41","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1007\/s10147-021-01962-4","volume":"26","author":"K Yugawa","year":"2021","unstructured":"Yugawa K, Itoh S, Yoshizumi T et al (2021) Lymphocyte-C-reactive protein ratio as a prognostic marker associated with the tumor immune microenvironment in intrahepatic cholangiocarcinoma. Int J Clin Oncol 26(10):1901\u20131910. https:\/\/doi.org\/10.1007\/s10147-021-01962-4","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"2861_CR42","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1186\/s12885-022-10145-x","volume":"22","author":"HY Zhang","year":"2022","unstructured":"Zhang HY, Xie HL, Ruan GT et al (2022) Lymphocyte to C-reactive protein ratio could better predict the prognosis of patients with stage IV cancer. BMC Cancer 22(1):1080. https:\/\/doi.org\/10.1186\/s12885-022-10145-x","journal-title":"BMC Cancer"}],"container-title":["Updates in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-026-02861-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13304-026-02861-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-026-02861-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:20:02Z","timestamp":1790655602000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13304-026-02861-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":42,"alternative-id":["2861"],"URL":"https:\/\/doi.org\/10.1007\/s13304-026-02861-x","relation":{},"ISSN":["2038-131X","2038-3312"],"issn-type":[{"value":"2038-131X","type":"print"},{"value":"2038-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"11 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was carried out based on the ethical guidelines of the\n                      Declaration of Helsinki\n                      and the clinical research-related norms and regulations, and conforming to the Enhancing the QUAlity and Transparency Of health Research network guidelines. This study was endorsed by the academic ethics committee of The First Hospital of Putian City and Putian Hanjiang Hospital. The requirement for informed consent was waived due to the retrospective nature of the study and the use of de-identified data.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report there are no competing interests to declare.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}